P Kjaerulff Nielsen

Learn More
OBJECTIVES To examine whether intermittent oral 1 alpha(OH)D3 treatment of patients on haemodialysis with secondary hyperparathyroidism (HPT) was able to maintain the marked suppression of PTH, which(More)
  • 1